0 XP   0   0   0

Appili Therapeutics Inc
Buy, Hold or Sell?

I guess you are interested in Appili Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Appili Therapeutics Inc

Let's start. I'm going to help you getting a better view of Appili Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Appili Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Appili Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Appili Therapeutics Inc. The closing price on 2022-09-29 was $0.039 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Appili Therapeutics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Appili Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Appili Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -58.2% means that $-0.58 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Appili Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-58.2%+58.2%
TTM-58.2%YOY--58.2%
TTM-58.2%5Y-59.0%+0.8%
5Y-59.0%10Y-59.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--241.1%+241.1%
TTM-58.2%-275.9%+217.7%
YOY--342.1%+342.1%
5Y-59.0%-475.7%+416.7%
10Y-59.0%-561.7%+502.7%
1.1.2. Return on Assets

Shows how efficient Appili Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • -25.3% Return on Assets means that Appili Therapeutics Inc generated $-0.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Appili Therapeutics Inc:

  • The MRQ is -32.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -25.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.6%TTM-25.3%-7.2%
TTM-25.3%YOY-29.8%+4.5%
TTM-25.3%5Y-26.1%+0.7%
5Y-26.1%10Y-26.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.6%-9.7%-22.9%
TTM-25.3%-8.7%-16.6%
YOY-29.8%-9.2%-20.6%
5Y-26.1%-11.5%-14.6%
10Y-26.1%-12.4%-13.7%
1.1.3. Return on Equity

Shows how efficient Appili Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means the company generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Appili Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-50.3%+50.3%
TTM-5Y-38.8%+38.8%
5Y-38.8%10Y-38.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.8%+11.8%
TTM--11.0%+11.0%
YOY-50.3%-10.6%-39.7%
5Y-38.8%-13.5%-25.3%
10Y-38.8%-14.5%-24.3%

1.2. Operating Efficiency of Appili Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Appili Therapeutics Inc is operating .

  • Measures how much profit Appili Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Appili Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-58.1%+58.1%
TTM-58.1%YOY--58.1%
TTM-58.1%5Y-57.5%-0.5%
5Y-57.5%10Y-57.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM-58.1%-269.6%+211.5%
YOY--309.3%+309.3%
5Y-57.5%-466.7%+409.2%
10Y-57.5%-572.5%+515.0%
1.2.2. Operating Ratio

Measures how efficient Appili Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.788-0.788
TTM0.788YOY-+0.788
TTM0.7885Y0.708+0.080
5Y0.70810Y0.7080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM0.7883.542-2.754
YOY-3.491-3.491
5Y0.7085.744-5.036
10Y0.7087.007-6.299

1.3. Liquidity of Appili Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Appili Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 198.6% means the company has $1.99 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 1.986. The company is able to pay all its short-term debts. +1
  • The TTM is 1.261. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.986TTM1.261+0.724
TTM1.261YOY6.675-5.414
TTM1.2615Y4.693-3.431
5Y4.69310Y4.6930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9865.266-3.280
TTM1.2616.060-4.799
YOY6.6756.365+0.310
5Y4.6936.692-1.999
10Y4.6936.457-1.764
1.3.2. Quick Ratio

Measures if Appili Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 30.9% means the company can pay off $0.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.309. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.194. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.309TTM0.194+0.116
TTM0.194YOY2.451-2.257
TTM0.1945Y1.451-1.257
5Y1.45110Y1.4510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3093.985-3.676
TTM0.1944.865-4.671
YOY2.4515.192-2.741
5Y1.4515.275-3.824
10Y1.4514.997-3.546

1.4. Solvency of Appili Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Appili Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 1.22 means that Appili Therapeutics Inc assets are financed with 122.2% credit (debt) and the remaining percentage (100% - 122.2%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 1.222. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.041. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.222TTM1.041+0.181
TTM1.041YOY0.279+0.761
TTM1.0415Y0.549+0.492
5Y0.54910Y0.5490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2220.271+0.951
TTM1.0410.269+0.772
YOY0.2790.296-0.017
5Y0.5490.361+0.188
10Y0.5490.399+0.150
1.4.2. Debt to Equity Ratio

Measures if Appili Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.258-0.258
TTM0.258YOY0.459-0.201
TTM0.2585Y0.632-0.374
5Y0.63210Y0.6320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.310-0.310
TTM0.2580.311-0.053
YOY0.4590.310+0.149
5Y0.6320.382+0.250
10Y0.6320.438+0.194

2. Market Valuation of Appili Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Appili Therapeutics Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.20 means the investor is paying $-0.20 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Appili Therapeutics Inc:

  • The EOD is -0.135. Company is losing money. -2
  • The MRQ is -0.200. Company is losing money. -2
  • The TTM is -0.652. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.135MRQ-0.200+0.066
MRQ-0.200TTM-0.652+0.451
TTM-0.652YOY-4.456+3.804
TTM-0.6525Y-1.836+1.184
5Y-1.83610Y-1.8360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.135-2.150+2.015
MRQ-0.200-2.332+2.132
TTM-0.652-3.889+3.237
YOY-4.456-5.087+0.631
5Y-1.836-3.697+1.861
10Y-1.836-3.390+1.554
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Appili Therapeutics Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.039. Very good. +2
  • The TTM is 0.006. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.039TTM0.006+0.033
TTM0.006YOY-0.070+0.076
TTM0.0065Y-0.027+0.033
5Y-0.02710Y-0.0270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0390.004+0.035
TTM0.0060.019-0.013
YOY-0.0700.042-0.112
5Y-0.0270.021-0.048
10Y-0.0270.017-0.044

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Appili Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -4.44 means the investor is paying $-4.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Appili Therapeutics Inc:

  • The EOD is -2.984. Bad. Book ratio is negative. -2
  • The MRQ is -4.438. Bad. Book ratio is negative. -2
  • The TTM is -3.035. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-2.984MRQ-4.438+1.454
MRQ-4.438TTM-3.035-1.403
TTM-3.035YOY4.152-7.187
TTM-3.0355Y0.453-3.488
5Y0.45310Y0.4530.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.9841.816-4.800
MRQ-4.4381.961-6.399
TTM-3.0352.789-5.824
YOY4.1523.538+0.614
5Y0.4532.782-2.329
10Y0.4532.419-1.966

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Appili Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share---0.0130.007-285%0.229-106%0.109-112%0.109-112%
Book Value Per Share Growth--0.033-0.027+181%-0.070+313%-0.001+104%-0.001+104%
Current Ratio--1.9861.261+57%6.675-70%4.693-58%4.693-58%
Debt To Asset Ratio--1.2221.041+17%0.279+337%0.549+123%0.549+123%
Debt To Equity Ratio---0.258-100%0.459-100%0.632-100%0.632-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.019-0.072+277%-0.076+298%-0.057+197%-0.057+197%
Eps Growth---5.137101.057-105%87.581-106%95.282-105%95.282-105%
Gains Per Share--0.033-0.027+181%-0.070+313%-0.001+104%-0.001+104%
Gross Profit Margin--1.0000.750+33%1.0000%0.929+8%0.929+8%
Net Profit Margin----0.5820%-0%-0.5900%-0.5900%
Operating Margin----0.5810%-0%-0.5750%-0.5750%
Operating Ratio---0.788-100%-0%0.708-100%0.708-100%
Pb Ratio-2.984+33%-4.438-3.035-32%4.152-207%0.453-1080%0.453-1080%
Pe Ratio-0.135+33%-0.200-0.652+225%-4.456+2122%-1.836+815%-1.836+815%
Peg Ratio--0.0390.006+542%-0.070+280%-0.027+168%-0.027+168%
Price Per Share0.039-49%0.0580.276-79%0.844-93%0.370-84%0.370-84%
Quick Ratio--0.3090.194+60%2.451-87%1.451-79%1.451-79%
Return On Assets---0.326-0.253-22%-0.298-8%-0.261-20%-0.261-20%
Return On Equity----0%-0.5030%-0.3880%-0.3880%
 EOD+1 -2MRQTTM+10 -6YOY+6 -85Y+8 -810Y+8 -8

3.2. Fundamental Score

Let's check the fundamental score of Appili Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.135
Price to Book Ratio (EOD)Between0-1-2.984
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.309
Current Ratio (MRQ)Greater than11.986
Debt to Asset Ratio (MRQ)Less than11.222
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.326
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Appili Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.953
Ma 20Greater thanMa 500.047
Ma 50Greater thanMa 1000.050
Ma 100Greater thanMa 2000.054
OpenGreater thanClose0.039
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets7,136
Total Liabilities8,721
Total Stockholder Equity-1,585
 As reported
Total Liabilities 8,721
Total Stockholder Equity+ -1,585
Total Assets = 7,136

Assets

Total Assets7,136
Total Current Assets7,120
Long-term Assets7,120
Total Current Assets
Cash And Cash Equivalents 5,554
Net Receivables 1,109
Total Current Assets  (as reported)7,120
Total Current Assets  (calculated)6,663
+/- 457
Long-term Assets
Property Plant Equipment 16
Long-term Assets  (as reported)16
Long-term Assets  (calculated)16
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,586
Long-term Liabilities5,135
Total Stockholder Equity-1,585
Total Current Liabilities
Short Long Term Debt 98
Accounts payable 3,370
Other Current Liabilities 118
Total Current Liabilities  (as reported)3,586
Total Current Liabilities  (calculated)3,585
+/- 1
Long-term Liabilities
Long term Debt 5,135
Long-term Liabilities  (as reported)5,135
Long-term Liabilities  (calculated)5,135
+/-0
Total Stockholder Equity
Common Stock42,323
Retained Earnings -58,394
Other Stockholders Equity 8,815
Total Stockholder Equity (as reported)-1,585
Total Stockholder Equity (calculated)-7,255
+/- 5,670
Other
Capital Stock42,323
Common Stock Shares Outstanding 121,266
Net Invested Capital 5,233
Net Tangible Assets -1,585
Net Working Capital 3,534



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
6,835
5,157
3,788
3,059
11,174
26,220
23,722
21,534
18,317
11,904
0
11,363
8,282
7,136
7,1368,28211,363011,90418,31721,53423,72226,22011,1743,0593,7885,1576,835
   > Total Current Assets 
6,755
5,081
3,716
2,991
11,111
26,160
23,662
21,477
18,262
11,852
11,843
11,316
8,239
7,120
7,1208,23911,31611,84311,85218,26221,47723,66226,16011,1112,9913,7165,0816,755
       Cash And Cash Equivalents 
5,421
4,175
3,041
2,408
10,510
5,526
12,857
15,236
11,063
9,302
0
9,372
6,665
5,554
5,5546,6659,37209,30211,06315,23612,8575,52610,5102,4083,0414,1755,421
       Short-term Investments 
30
31
31
30
31
20,034
10,055
5,052
5,062
30
0
0
0
0
0000305,0625,05210,05520,0343130313130
       Net Receivables 
0
0
369
351
313
405
417
722
1,686
2,342
1,507
1,706
1,391
1,109
1,1091,3911,7061,5072,3421,68672241740531335136900
       Inventory 
104
104
104
39
39
0
0
0
0
0
0
0
0
0
0000000003939104104104
   > Long-term Assets 
80
76
72
68
63
61
60
57
55
52
0
47
42
16
164247052555760616368727680
       Property Plant Equipment 
80
76
72
68
63
61
60
57
55
52
50
47
42
16
1642475052555760616368727680
> Total Liabilities 
2,415
2,280
1,941
2,328
2,328
3,282
2,682
4,165
5,564
6,042
0
11,797
11,552
8,721
8,72111,55211,79706,0425,5644,1652,6823,2822,3282,3281,9412,2802,415
   > Total Current Liabilities 
1,350
1,338
997
1,396
1,378
2,332
1,723
3,210
4,617
5,115
15,130
10,872
6,669
3,586
3,5866,66910,87215,1305,1154,6173,2101,7232,3321,3781,3969971,3381,350
       Short Long Term Debt 
53
58
64
79
55
55
55
83
85
88
0
2,078
96
98
98962,078088858355555579645853
       Accounts payable 
1,288
1,280
889
1,258
1,263
2,278
1,661
3,122
4,449
5,027
10,983
8,789
6,382
3,370
3,3706,3828,78910,9835,0274,4493,1221,6612,2781,2631,2588891,2801,288
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
1,266
0
118
118
11811801,2660000000000
   > Long-term Liabilities 
1,066
942
944
933
951
950
959
955
947
927
0
924
4,883
5,135
5,1354,88392409279479559599509519339449421,066
       Long term Debt 
1,066
942
944
933
951
950
959
955
947
927
0
924
4,883
5,135
5,1354,88392409279479559599509519339449421,066
> Total Stockholder Equity
4,420
2,877
1,847
731
8,845
22,939
21,041
17,369
12,753
5,862
0
-434
-3,271
-1,585
-1,585-3,271-43405,86212,75317,36921,04122,9398,8457311,8472,8774,420
   Common Stock
11,082
14,161
14,161
14,161
20,992
33,804
33,908
34,707
34,962
35,030
35,030
39,653
39,653
42,323
42,32339,65339,65335,03035,03034,96234,70733,90833,80420,99214,16114,16114,16111,082
   Retained Earnings -58,394-56,069-52,736-49,497-38,320-30,951-25,966-21,699-19,224-16,626-15,339-14,158-13,008-11,209
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
3,239
332
328
307
2,666
6,434
6,415
6,270
6,189
6,025
6,609
8,295
8,132
8,815
8,8158,1328,2956,6096,0256,1896,2706,4156,4342,6663073283323,239



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue1,391
Cost of Revenue--
Gross Profit-1,391
 
Operating Income (+$)
Gross Profit-
Operating Expense-24,949
Operating Income-23,559-24,949
 
Operating Expense (+$)
Research Development20,744
Selling General Administrative5,268
Selling And Marketing Expenses-
Operating Expense24,94926,012
 
Net Interest Income (+$)
Interest Income34
Interest Expense-1,555
Net Interest Income-1,521-1,521
 
Pretax Income (+$)
Operating Income-23,559
Net Interest Income-1,521
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-25,080-23,559
EBIT - interestExpense = -26,177
-25,080
-23,563
Interest Expense1,555
Earnings Before Interest and Taxes (ebit)-24,622-23,525
Earnings Before Interest and Taxes (ebitda)-23,512
 
After tax Income (+$)
Income Before Tax-25,080
Tax Provision-38
Net Income From Continuing Ops-25,118-25,118
Net Income-25,118
Net Income Applicable To Common Shares-25,118
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,521
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SKUE.OL
4 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SKUE.OL.

SKUE.OL Daily Candlestick Chart
AERS.LSE
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AERS.LSE.

AERS.LSE Daily Candlestick Chart
VIA.CC
5 hours ago

I found you a Death Cross on the daily chart of VIA.CC.

VIA.CC Daily Candlestick Chart
VELO.CC
5 hours ago

I found you a RSI Bearish Hidden Divergence on the daily chart of VELO.CC.

VELO.CC Daily Candlestick Chart
vBUSD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of vBUSD.CC.

vBUSD.CC Daily Candlestick Chart
UNW.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of UNW.CC.

UNW.CC Daily Candlestick Chart
TWTR.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TWTR.CC.

TWTR.CC Daily Candlestick Chart
TMN.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TMN.CC.

TMN.CC Daily Candlestick Chart
TEL.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
WFAFY.PINK
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WFAFY.PINK.

WFAFY.PINK Daily Candlestick Chart
BOCT.BATS
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BOCT.BATS.

BOCT.BATS Daily Candlestick Chart
BATT.NYSE ARC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BATT.NYSE ARC.

BATT.NYSE ARC Daily Candlestick Chart
ASXFY.PINK
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASXFY.PINK.

ASXFY.PINK Daily Candlestick Chart
ARKQ.BATS
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ARKQ.BATS.

ARKQ.BATS Daily Candlestick Chart
AGZ.NYSE ARC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AGZ.NYSE ARC.

AGZ.NYSE ARC Daily Candlestick Chart
ADDDF.OTCQX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ADDDF.OTCQX.

ADDDF.OTCQX Daily Candlestick Chart
ACWI.NASDAQ
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ACWI.NASDAQ.

ACWI.NASDAQ Daily Candlestick Chart
JQUA.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of JQUA.NYSE ARC.

JQUA.NYSE ARC Daily Candlestick Chart
ZIG.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ZIG.NYSE ARC.

ZIG.NYSE ARC Daily Candlestick Chart
YINN.NYSE ARC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of YINN.NYSE ARC.

YINN.NYSE ARC Daily Candlestick Chart
XSVM.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XSVM.NYSE ARC.

XSVM.NYSE ARC Daily Candlestick Chart
XOUT.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XOUT.NYSE ARC.

XOUT.NYSE ARC Daily Candlestick Chart
XNTK.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XNTK.NYSE ARC.

XNTK.NYSE ARC Daily Candlestick Chart